ENTPD1 and neoplasm: In 2018, Doohen et al. proved that CD103+, CD39+, and CD8 TILs are unique tumor-reactive cells in the tumor microenvironment, which can be isolated from the tumor digests by immunomagnetic beads and fluorescence-activated cell sorting (FACS) [43].